An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma

Silvia Mara Baez Rodriguez,Amira Kamel,Gheorghe Vasile Ciubotaru,Gelu Onose,Ani-Simona Sevastre,Veronica Sfredel,Suzana Danoiu,Anica Dricu,Ligia Gabriela Tataranu

DOI: https://doi.org/10.3390/ijms241311110

IF: 5.6

2023-07-05

International Journal of Molecular Sciences

Abstract:Despite all of the progress in understanding its molecular biology and pathogenesis, glioblastoma (GBM) is one of the most aggressive types of cancers, and without an efficient treatment modality at the moment, it remains largely incurable. Nowadays, one of the most frequently studied molecules with important implications in the pathogenesis of the classical subtype of GBM is the epidermal growth factor receptor (EGFR). Although many clinical trials aiming to study EGFR targeted therapies have been performed, none of them have reported promising clinical results when used in glioma patients. The resistance of GBM to these therapies was proven to be both acquired and innate, and it seems to be influenced by a cumulus of factors such as ineffective blood–brain barrier penetration, mutations, heterogeneity and compensatory signaling pathways. Recently, it was shown that EGFR possesses kinase-independent (KID) pro-survival functions in cancer cells. It seems imperative to understand how the EGFR signaling pathways function and how they interconnect with other pathways. Furthermore, it is important to identify the mechanisms of drug resistance and to develop better tailored therapeutic agents.

biochemistry & molecular biology,chemistry, multidisciplinary